Our mechanistic studies explain why Aurora kinase A and PLK1 inhibition alone or in combination with WEE1 inhibition induce apoptosis in TKI-sensitive and -resistant BCR::ABL1+ cell lines and in multi-TKI-resistant BC CML patient cells. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.